33.7 C
Vientiane
Monday, July 7, 2025
spot_img
Home Blog Page 243

HTX and Justin Sun Launch $6M Mars Program Special Edition, Offering One User a Historic Space Journey

SINGAPORE, May 8, 2025 /PRNewswire/ — HTX, a leading global cryptocurrency exchange, has launched the Mars Program: Special Edition, a landmark campaign that will send one user on a $6 million space voyage, fully sponsored by Justin Sun, Advisor to HTX, and Founder of TRON.

The campaign runs from May 7, 08:00 to May 13, 04:00 (UTC). All users who completed Level 3 KYC verification on HTX are eligible to apply. Five new finalists will be selected based on registration date, trading activity, net fee contribution, and asset balance. They will join seven existing candidates, forming a group of 12, from which one winner will be chosen to embark on a space journey with Justin Sun in July 2025.

Campaign Details: https://www.htx.com.pk/support/25000906493178

A $6M Journey Beyond Earth

Justin Sun, one of the most prominent figures in the crypto industry, is personally funding the $6 million ticket for this mission. Known for his headline-making initiatives across Web3 and traditional finance, Sun aims to make space more accessible to the global crypto community.

“This mission isn’t about elites or executives—it’s about empowering users,” said Justin Sun. “Space exploration should be accessible. With this journey, we want to bring the crypto spirit beyond Earth’s limits.”

The Mars Program: Empowering Global Participation

HTX’s Mars Program has completed seven successful rounds, selecting seven individuals for potential space missions. The Special Edition marks a bold new chapter, opening participation to a broader group of users worldwide.

Rather than offering exclusive experiences to elites, HTX is extending a chance for everyday users to make history. The initiative reflects HTX’s vision of Web3 as an open, inclusive ecosystem—where breakthroughs in technology, finance, and culture converge.

Bridging Crypto and Cosmos

The Mars Program is more than a campaign—it’s a symbol of Web3’s potential to reshape real-world possibilities. HTX continues to explore how blockchain can extend beyond financial infrastructure and into personal dreams, collective imagination, and global narratives.

With this initiative, HTX positions itself at the forefront of innovation—not just in trading or technology, but in inspiring the next generation of crypto pioneers.

How to Participate

Users must complete Level 3 KYC on HTX and submit an application before the campaign ends. The winner, selected from 12 total finalists, will be announced ahead of the July 2025 launch.

About HTX

Founded in 2013, HTX has evolved from a virtual asset exchange into a comprehensive ecosystem of blockchain businesses that span digital asset trading, financial derivatives, research, investments, incubation, and other businesses.

As a world-leading gateway to Web3, HTX harbors global capabilities that enable it to provide users with safe and reliable services. Adhering to the growth strategy of “Global Expansion, Thriving Ecosystem, Wealth Effect, Security & Compliance,” HTX is dedicated to providing quality services and values to virtual asset enthusiasts worldwide.

To learn more about HTX, please visit HTX Square or https://www.htx.com/, and follow HTX on X, Telegram, and Discord.

TINECO INTRODUCES FLOOR ONE S7 STRETCH ULTRA: SMART FLOOR CLEANING WITH UNMATCHED FLEXIBILITY

Longer Runtime, Innovative DualBlock Anti-Tangle Design, and Enhanced Self-Cleaning Build on the Success of the Beloved Stretch S6

SEATTLE, May 8, 2025 /PRNewswire/ — Tineco, a global leader in intelligent home appliances, today announces the launch of the FLOOR ONE S7 Stretch Ultra, a next-generation smart floor washer that offers extended runtime, upgraded anti-tangle technology, and an optimized self-cleaning system. Building on the success of the FLOOR ONE Stretch S6, this new model is designed to deliver even more convenience and efficiency without compromising on the features users already love.

TINECO INTRODUCES FLOOR ONE S7 STRETCH ULTRA: SMART FLOOR CLEANING WITH UNMATCHED FLEXIBILITY
TINECO INTRODUCES FLOOR ONE S7 STRETCH ULTRA: SMART FLOOR CLEANING WITH UNMATCHED FLEXIBILITY

With a 180° Lay-Flat Design, the FLOOR ONE S7 Stretch Ultra maintains the hallmark reach and maneuverability of its predecessor while introducing an advanced DualBlock™ Anti-Tangle Design and a prolonged battery life to support longer, more efficient cleaning sessions. The enhanced FlashDry™ Self-Cleaning System also preserves the highly valued routine users rely on, now using 185°F heated water and hot air, up from the previous 153°F, for a deeper clean and superior drying.

Tineco’s intelligent iLoop™ Smart Sensor Technology continues to power real-time adjustments for suction and water flow, ensuring exceptional results with minimal effort. Additional key features of the FLOOR ONE S7 Stretch Ultra include:

  • Extended Runtime: Maximized battery life delivers up to 50 minutes of cleaning on a single charge.
  • DualBlock™ Anti-Tangle Design: A two-part scraper system with a front comb and straight edge captures and removes hair and debris, minimizing tangles and keeping the brush cleaner for longer.
  • 180° Flex Design: Stretches completely flat to reach under beds, couches, and tight spaces without moving heavy furniture.
  • All-in-One LED Display: Real-time feedback on performance, battery life, and cleaning status.
  • Dual Tank System: Keeps clean and dirty water separate for a consistently fresh clean.
  • Dual-sided Edge Cleaning: Glides closely along baseboards, ensuring that every corner is thoroughly cleaned.

The FLOOR ONE S7 Stretch Ultra is ideal for households seeking a smarter and more powerful cleaning solution, especially in homes with pets, children, or open floor plans that demand comprehensive and efficient maintenance.

The FLOOR ONE S7 Stretch Ultra is now available on the Tineco online store and  Amazon for $699. To learn more about Tineco and its full suite of floor care solutions, including vacuums, floor washers, and carpet cleaners, visit https://www.tineco.com.

About Tineco
Tineco was founded in 1998 with its first SKU as a vacuum cleaner and, in 2019, pioneered the first-ever smart vacuum. Today, the brand has innovated into a global leader offering intelligent appliances across home categories, including floor care, kitchen, and personal care. Tineco is dedicated to its brand vision of making life easier through smart technologies and consistently innovating new devices.

For more information, please visit https://www.tineco.com.

From Patient to Pioneer: jinIX Supports Nathan Ehrlich’s Mission for Rare Disease Research

SAN FRANCISCO, May 8, 2025 /PRNewswire/ — The jinIX Foundation hosted a meaningful and inspiring gathering—not just to mark the launch of its non-profit initiative, but to honor Nathan Ehrlich, a young rare disease advocate whose courage and vision are helping to reshape the future of patient-led clinical research.

jinIX Foundation, a nonprofit foundation, in collaboration with jinIX Cosmos Inc., develops digital health platform designed to improve the lives of rare disease patients. It offers an AI-powered symptom checker to help patients recognize early signs of rare diseases, and uses blockchain to keep medical data secure, private, and under the patient’s control. jinIX also builds tools to help patients share their data for research and connect with the right doctors and studies. Its mission is to make diagnosis faster, data more trustworthy, and clinical research more accessible to those who have been overlooked by traditional healthcare systems.

Diagnosed with leukemia at 16 and later found to carry a rare SAMD9L gene mutation, Nathan now lives with symptoms similar to Amyotrophic Lateral Sclerosis. For years, he faced uncertainty, fragmented care, and little hope for progress. But rather than give up, Nathan chose to fight—not only to uncover the root cause of his illness, but also to pursue a cure. He is not fighting just for himself, but for an entire community of patients like him.

To support this mission, Nathan founded the SAMD9L Foundation, a nonprofit dedicated to raising awareness, accelerating research, and building community for individuals and families affected by SAMD9L-related conditions.

At the event, Nathan shared his story publicly outlined his mission to launch a patient-led clinical trial, raise awareness for SAMD9L-related conditions, and build a global data and support network for others facing similar challenges.

“It takes a decade for an average rare disease patient to get a diagnosis. Most of us feel invisible,” Nathan said. “But with jinIX, something changed. They listened. They helped me turn my story into a study. Together, we’re not just searching for a cure—we’re building a movement.”

jinIX is working with the SAMD9L Foundation, which Nathan founded, to support a groundbreaking natural history study guided by Dr. David Putrino at Mount Sinai, NY. The project will collect electronic health journey data from patients with SAMD9L mutations and related conditions to better understand disease progression and treatment needs. jinIX’s role is to provide secure infrastructure, data management, and patient coordination for this work.

“This study is a new model for what patient-led, data-powered research can look like,” said Jeffrey Zhang, CEO of jinIX

Also in attendance was Patty DeDominic, a board member of the jinIX Foundation, founder of DeDominic & Associates, and a longtime advocate for women- and patient-led innovation:

“Nathan isn’t just a patient—he’s a pioneer,” Patty said. “jinIX exists to support visionaries like him, giving them the tools, technology, and partnerships to lead the way forward.”

The event closed with a performance of an original song, “The World Is Beautiful Because of Me,” composed to honor Nathan and the rare disease community. The gathering marked not just a launch, but a movement—one built on collaboration, compassion, and the belief that patient voices can guide meaningful change.

As jinIX continues to grow, it is expanding collaborations with researchers, physicians, and patient advocacy groups around the world. But its foundation will always be rooted in stories like Nathan’s—proof that real change begins when patients are trusted and empowered to lead.

To learn more about Nathan’s journey and support us, please visit https://www.samd9lfoundation.org/ or contact jinIX (www.jinix.io) via contact@jinix.io.

Hot Tech Innovators: ABI Research Names Globalstar, Iridium, and EchoStar MobileAmong 8 Top Satellite Operators Innovating in the IoT Market

NEW YORK, May 8, 2025 /PRNewswire/ — ABI Research, a global technology intelligence firm, awarded eight satellite operators a “Hot Tech Innovator” title for their contributions to the satellite IoT industry. Each awarded operator has been instrumental in maturing the satellite IoT ecosystem, creating new standards-based services or investing in large, IoT-compatible constellations to expand IoT customers’ options beyond terrestrial limits.

-

“Though it is ramping up, the satellite IoT market has developed a reputation of being out-of-step with IoT customers’ pricing and power requirements,” says Lizzie Stokes, Senior. Analyst at ABI Research. “Each of these Hot Tech Innovators is responsible for reversing that trend, bringing to market new technologies and service offerings that are both innovative and IoT-friendly.”

One Innovator, Globalstar, is known for its affordable IoT services. Its historical focus on one-way messaging in IoT-heavy markets, like asset tracking, has allowed the company to become an expert in low-cost, low-data communications. It will continue its accessible legacy by introducing a new two-way messaging offering. Globalstar’s accompanying LTE and 5G terrestrial spectrum for private networks is also an important differentiator, allowing the company to become a comprehensive connectivity provider. Iridium, another awarded Innovator, has focused its IoT innovation efforts around multi-mode capabilities, announcing in January 2024 its own 3GPP NTN service. This service will shake up the satellite IoT competitive landscape, as it competes directly with the 3GPP NTN services offered by two other Hot Tech Innovators, Sateliot and OQ Technology.

Though fairly new to the market, Sateliot and OQ Technology have been at the forefront of 3GPP NTN adoption, building LEO constellations based on the new standard. Both companies are forming cellular partnerships with influential MNOs and MVNOs to grow their platforms as their satellite infrastructure ramps up.

The LoRa NTN standard is also pertinent to satellites’ uptake in the IoT world, serving as an NTN technology that suits the IoT’s cost and power constraints. Hot Tech Innovators Lacuna Space and EchoStar Mobile are taking different paths to the standard’s adoption, with EchoStar Mobile primarily focusing on its pan-European LoRa NTN while Lacuna Space builds its constellation and expands into new markets.

Starlink is another influential player in the satellite IoT market, with plans to offer an IoT service in 2025. The company has an impressive mega-constellation of 6,791 LEO satellites as of October 2024. However, Starlink’s dominance could face competition from Amazon as it invests in its own satellite company, Amazon Project Kuiper. Amazon Project Kuiper also plans to use a huge constellation of LEO satellites to support a wide range of customer segments, from broadband services to IoT devices.

“A satellite operator’s success in the IoT market depends on various factors. The size of its constellation, its orbital regime, and its chosen protocols can affect how an operator appeals to an asset tracking or condition-based monitoring customer,” says Stokes. “Each operator listed in this report has displayed a thorough understanding of the IoT’s inherent constraints and prioritized offerings that will bring more IoT users into the non-terrestrial market.”

These findings are from ABI Research’s Hot Tech Innovators: Satellite IoT Platforms report. This report is part of the company’s IoT Networks and Platforms research service, which includes research, data, and ABI Insights.

About ABI Research

ABI Research is a global technology intelligence firm uniquely positioned at the intersection of technology solution providers and end-market companies. We serve as the bridge that seamlessly connects these two segments by providing exclusive research and expert guidance to drive successful technology implementations and deliver strategies proven to attract and retain customers.

ABI Research是一家全球性的技术情报公司,拥有得天独厚的优势,充当终端市场公司和技术解决方案提供商之间的桥梁,通过提供独家研究和专业性指导,推动成功的技术实施和提供经证明可吸引和留住客户的战略,无缝连接这两大主体。

For more information about ABI Research’s services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific, or visit www.abiresearch.com.

Contact Info

Global
Deborah Petrara
Tel: +1.516.624.2558
pr@abiresearch.com

BioDlink Congratulates Junshi Biosciences on IND Approval of JS212, a Bispecific ADC Therapeutic Candidate

  • BioDlink congratulates Junshi Biosciences on receiving IND approval from China’s NMPA for JS212, the company’s first bispecific ADC.
  • JS212 combines dual-targeting antibody technology with a cytotoxic payload, representing a next-generation therapeutic.
  • BioDlink provided end-to-end development and manufacturing support, showcasing its industry-leading ADC capabilities.
  • Approval marks a key milestone in the development of next-generation antibody-drug conjugates.

SUZHOU, China, May 8, 2025 /PRNewswire/ — BioDlink, a leading global CDMO, proudly congratulates its partner Junshi Biosciences (HKEX-1877; SSE-688180), on receiving Investigational New Drug (IND) approval from the National Medical Products Administration (NMPA) of China to initiate clinical trials for the JS212 injection — Junshi Biosciences’ first bispecific antibody-drug conjugate (ADC).

JS212 represents a new class of bispecific ADCs that combine the humanized epidermal growth factor receptor and human epidermal growth factor receptor 3 bispecific antibody-drug conjugate to target both EGFR and HER3 — two proteins highly expressed in a variety of tumor cells, such as lung cancer, breast cancer, and head and neck cancer. As a bispecific ADC, JS212 has a key advantage over traditional ADCs that only target one protein: it can attack tumors via either EGFR or HER3, potentially increasing its effectiveness against a wider range of cancers and helping to overcome drug resistance.

Dr. Jun Liu, CEO and Executive Director of BioDlink, stated: “As a leader in ADC technology, BioDlink remains committed to technology innovation and one-stop solution platform for complex biologics. Our collaboration with Junshi Biosciences is built on mutual trust and deep experience in ADC research, development and manufacturing. The IND approval of JS212 — a technically demanding bispecific ADC —­ highlights our strong capabilities and strategic value we bring to partners pursuing next-generation biologics. We’re honored to support the advancement of this important program.”

Dr. Jing Tong, Deputy Director of Junshi Biosciences’ Innovation Research Institute, shared: “We are very pleased with the ongoing and highly productive partnership with BioDlink. Their exceptional expertise and proven capabilities in ADC development and manufacturing have played a pivotal role in advancing JS212 to this important milestone. Throughout the collaboration, BioDlink has consistently demonstrated technical excellence, operational efficiency, and a deep understanding of complex bispecific ADCs. This approval marks a key collaboration milestone, and we look forward to deepening our cooperation as we work toward bringing innovative therapies to patients in the future.”

BioDlink is committed to becoming a trusted CDMO biologics partner. The company operates a large-scale commercial biologics production site that meets international GMP standards and includes multiple integrated production lines for antibodies and ADCs.

With a comprehensive ADC platform supported by key R&D technologies, BioDlink enables efficient, centralized production of antibody intermediates, drug substances, and finished products. This setup accelerates timelines and reduces tech transfer costs. At the same time, BioDlink’s quality system is built according to international standards and has passed GMP audits in multiple countries, which can empower global customers.

About BioDlink Biopharm Co., Ltd.

With over 10 years of experience in antibody and ADC drug development, BioDlink offers full-service CDMO solutions for biologic drugs — from early-stage R&D through to commercial production.

The company has built integrated platforms for biologics and bioconjugates, offering process development, scale-up, and quality analytics solutions. Its scalable manufacturing lines include top-tier OEB-5 facilities for high-potency ADCs, with commercial antibody production already underway.

BioDlink’s quality management system complies with regulatory requirements in China, the U.S., the EU, and Japan. The company has successfully supported over 100 projects with development, clinical filings, and manufacturing services. In addition, the company has already passed near 100 GMP audits, including a zero-defect EU QP audit, with its quality systems earning worldwide recognition.

Guided by its “Empowering Innovation with Quality to Grow Together” mission, BioDlink is dedicated to enabling partners and advancing global healthcare through excellence in biologics.

About Shanghai Junshi Biosciences Co., Ltd.

Founded in December 2012, Junshi Biosciences (HKEX: 1877; SSE: 688180) is an innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapeutics. The company has established a diversified R&D pipeline comprising over 50 drug candidates, with five therapeutic focus areas covering cancer, autoimmune, metabolic, neurological, and infectious diseases. Five of the company’s products have received approvals in China and international markets, one of which is toripalimab, China’s first domestically produced and independently developed anti-PD-1 monoclonal antibody. Toripalimab has been approved in over 35 countries and regions including China, the US, and Europe. During the COVID-19 pandemic, Junshi Biosciences actively shouldered the social responsibilities of a Chinese pharmaceutical company through its involvement in developing etesevimab, MINDEWEI®, and other novel therapies for the prevention and treatment of COVID-19.

With a mission of “providing patients with world-class, trustworthy, affordable, and innovative drugs,” Junshi Biosciences is “In China, For Global.” At present, the company boasts approximately 2,500 employees in the United States (Maryland) and China (Shanghai, Suzhou, Beijing, Guangzhou, etc.).

Yas Island Celebrates Announcement of Disney Theme Park Resort with a Record-Breaking Drone Show, Landmark Illuminations, Live Performances and Fireworks Spectacular

  • Over 9,000 drones lit up Yas Island’s sky in celebration of the landmark announcement of the Middle East’s first-ever Disney theme park resort destination
  • Global Celebrities – Tyrese Gibson, Naomi Campbell, Nancy Ajram, Chiara Ferragni, and Ed Westwick joined the celebrations on Wednesday May 7th on Yas Island
  • Guests were treated to a live performance featuring world-renowned pianist Lang Lang alongside beloved Emirati icon, Rashed Alnuaimi, Kerry Ellis and Sonya Balsara
  • Iconic UAE landmarks including Burj Khalifa and Aldar HQ lit up with dazzling visuals

Download show celebration video here
Download high-resolution images here

ABU DHABI, UAE, May 8, 2025 /PRNewswire/ — History was made last night as Miral and The Walt Disney Company celebrated the official announcement of the Middle East and Africa’s first-ever Disney theme park resort destination with a record breaking 9,000 drone show and fireworks spectacle. The show, which took place at Yas Links, also featured a live performance of world-renowned pianist Lang Lang alongside iconic Emirati singer Rashed Alnuaimi, queen of the West End, Kerry Ellis and classical sensation, Sonya Balsara.

Yas Island Celebrates Disney Theme Park Resort Show
Yas Island Celebrates Disney Theme Park Resort Show

This glittering celebration also attracted global celebrities including Tyrese Gibson, Naomi Campbell, Nancy Ajram, Chiara Ferragni, and Ed Westwick, dignitaries, entertainment industry leaders and media powerhouses, all converging to witness the unveiling of what promises to be a game-changing chapter in Disney’s legacy, and in the evolution of Yas Island as a global destination for entertainment.

Set against the stunning backdrop of Yas Island’s waterfront, the sky came alive with the largest drone light show ever staged in the region, symbolizing the spirit of imagination that defines both brands. This new destination project will be Disney’s seventh theme park resort worldwide and the first in the Middle East, connecting travelers from the Middle East to Africa, India, Asia, Europe, and beyond.

Celebrating the announcement, landmarks across the UAE, including Burj Khalifa and Aldar HQ came to life with a spectacular light show inspired by the magic of Disney. In Abu Dhabi, iconic buildings also lit up in blue, marking the start of an extraordinary chapter in entertainment and tourism.

The upcoming resort promises to seamlessly blend Disney’s legendary storytelling and attractions with Abu Dhabi’s vibrant culture, awe-inspiring shorelines, and iconic architecture. The new resort will be fully developed and built by Miral. Disney and its legendary Imagineers will lead creative design and operational oversight to provide a world-class experience.

The announcement celebration signals not only a major milestone for Miral and Disney but also reinforces Yas Island’s position as a global hub for entertainment, tourism, and leisure.

Details of the new resort will be revealed as the project progresses.

 

Yas Island Celebrates Disney Theme Park Resort Show
Yas Island Celebrates Disney Theme Park Resort Show

 

Yas Island Celebrates Disney Theme Park Resort Show
Yas Island Celebrates Disney Theme Park Resort Show

Tire Bank Group Acquires Controlling Stake in Air Premia

Paving the Way for Stronger Governance and Global Expansion of Korea’s Leading Hybrid Airline

SEOUL, South Korea, May 8, 2025 /PRNewswire/ — Tire Bank Group has officially acquired a controlling stake in Air Premia(CEO Kim Jae-hyun, Yoo Myung-sub), Korea’s first long-haul hybrid airline, reinforcing its commitment to advancing the country’s aviation industry on a global scale.

Tire Bank Group
Tire Bank Group

On April 30, 2025, Tire Bank Group signed a definitive agreement to acquire an additional 22% equity stake in Air Premia from JC SPC and Sono International. This acquisition raises the Group’s total ownership to over 70%, solidifying its position as the airline’s majority shareholder.

Since Air Premia’s launch in 2018, Tire Bank Group has played a pivotal role in supporting the airline’s development through strategic investments. Despite global headwinds and the unprecedented impact of the COVID-19 pandemic, Air Premia has demonstrated remarkable operational resilience and adaptability.

Tire Bank Group maintained unwavering confidence in the airline’s potential, steadily increasing its ownership to 48% during turbulent times. Now, with a controlling interest, the Group is positioned to drive responsible management practices and long-term growth strategies.

Fleet and Route Expansion Underway

Air Premia is actively expanding its fleet and route network as part of its mid- to long-term growth plan. The airline currently operates seven Boeing 787-9 aircraft, with two additional aircraft set to be introduced later this year. Beginning July 2, the carrier will launch a new route to Honolulu, Hawaii – its fourth scheduled destination in the USA. To bolster operational stability, additional spare engines have also been secured.

Executive Statement

“Airlines are more than businesses—they represent the dignity and global standing of a nation,” said Kim Jeong-kyu, Chairman of Tire Bank Group. “We are committed to building Air Premia into a premium hybrid airline that proudly represents Korea and elevates its presence in the global aviation market.”

About Tire Bank Group

Founded in 1991, Tire Bank is Korea’s first and only dedicated tire distribution company, operating 501 stores across the country. With a customer-first philosophy, the company has introduced a range of industry-first services, including a tire warranty program, tire hotel premium storage service, and an emergency response program for tire-related issues. Tire Bank also actively contributes to local communities through various charitable and donation initiatives.

For media contact, or additional information, please contact:
Seung Shin Park
ss.park@airpremia.com
https://www.airpremia.com/

Air Premia
Air Premia

Gates Foundation Will Double Spending Over Next 20 Years to Accelerate Progress on Saving and Improving Lives

On foundation’s 25th anniversary, Bill Gates outlines ambitious goals, inspiration for donating most of his resources and new timeline to spend-down by 2045

SEATTLE, May 8, 2025 /PRNewswire/ — On the occasion of its 25th year, the Gates Foundation today made a new commitment to accelerate its mission to help all people live healthy, productive lives by spending $200 billion over the next 20 years. The decision marks a major acceleration in the foundation’s work and sets a new date of 2045 to sunset its operations. The historic announcement, which represents the largest philanthropic commitment in modern history, was shared in a post by foundation Chair Bill Gates.

“There are too many urgent problems to solve for me to hold onto resources that could be used to help people. That is why I have decided to give my money back to society much faster than I had originally planned,” writes Gates. “I will give away virtually all my wealth through the Gates Foundation over the next 20 years to the cause of saving and improving lives around the world.”

The accelerated timeline was affirmed by the foundation’s board of directors with a change to the foundation’s charter, which had said the organization would sunset 20 years after Gates’ death. The funding pledged exceeds the foundation’s current endowment, with the balance coming over time from Gates’ personal fortune.

“A few years ago, I began to rethink that [timeline]. More recently, with the input from our board, I now believe we can achieve the foundation’s goals on a shorter timeline, especially if we double down on key investments and provide more certainty to our partners,” writes Gates.

While the foundation’s strategies are not changing, over the next two decades, the foundation will work together with its partners to make as much progress as possible towards three primary goals:

  • Help end preventable deaths of moms and babies
  • Ensure the next generation grows up without having to suffer from deadly infectious diseases
  • Lift millions of people out of poverty, putting them on a path to prosperity

“During the first 25 years of the Gates Foundation—powered in part by the generosity of Warren Buffett—we gave away more than $100 billion,” writes Gates. “Over the next two decades, we will double our giving. The exact amount will depend on the markets and inflation, but I expect the foundation will spend more than $200 billion between now and 2045. This figure includes the balance of the endowment and my future contributions.”

The shift in the sunset date is driven by urgency and opportunity. The foundation hopes to capitalize on the extraordinary global progress in health and development between 2000 and 2025—a period when child deaths were halved, deaths from deadly infectious diseases were significantly reduced, and hundreds of millions of people rose out of poverty.

Since 2000, the Gates Foundation contributed to saving 82 million lives through its support of Gavi, the Vaccine Alliance and the Global Fund to Fight AIDS, Tuberculosis and Malaria. Together with its partners, the foundation also helped develop more than 100 innovations, including vaccines, diagnostic tools, and treatments designed to meet the needs of people living in low- and middle-income countries. Taken together, these innovations—and the people who made them possible—helped change the trajectory of global health. Still, there are hundreds more innovations in the pipeline.

“The needs at this time are greater than any we’ve seen in the lifetime of the foundation, but the achievements of the past 25 years have shown the tremendous progress that is still possible,” said Mark Suzman, CEO and board member of the Gates Foundation. “That’s why, in the next two decades, working in close collaboration with our partners, we’ll deploy these new innovations and apply 25 years of learnings and progress to making an even bigger difference.”

This announcement comes amidst multiple years of stagnant or, in some cases, backsliding progress on global health metrics. Governments around the world have announced tens of billions of dollars in cuts to aid funding that stand to have devastating consequences for the world’s poorest people.

At the same time, scientific breakthroughs, powerful innovations, and new tools—from vaccines to AI—are creating opportunities to save and improve lives faster than ever before.

“The truth is, there have never been more opportunities to help people live healthier, more prosperous lives. Advances in technology are happening faster than ever, especially with artificial intelligence on the rise,” writes Gates. “Even with all the challenges that the world faces, I’m optimistic about our ability to make progress—because each breakthrough is yet another chance to make someone’s life better.”

The 20-year timeline also allows the foundation to further its work strengthening the philanthropic sector. This concerted effort aims to ensure the institutions that outlast it—from nonprofits to local health institutions to multilateral partnerships—have the runway they need to plan for the future.

Additional areas of focus for the foundation’s work continue to be:

  • Helping U.S. students have pathways to opportunity
  • Strengthening digital public infrastructure so more people have access to the financial and social services that foster inclusive economies and open, competitive markets
  • Applying new uses of artificial intelligence, which can accelerate the quality and reach of services, from health to education to agriculture
  • Lifting up women, their families, and their communities by advancing gender equality to help women access education, health care, and financial services

“The work of making the world better is and always has been a group effort. I am proud of everything the foundation accomplished during its first 25 years, but I also know that none of it would have been possible without fantastic partners,” says Gates. “I believe we can leave the next generation better off and better prepared to fight the next set of challenges.”

Earlier this year, the foundation announced its largest budget ever, in line with the foundation’s commitment to reach overall annual distributions of US$9 billion next year.

Additional relevant resources can be found in the Digital Press Kit, which include fact sheets, images and more.

About the Gates Foundation
Guided by the belief that every life has equal value, the Gates Foundation works to help all people lead healthy, productive lives. In developing countries, we work with partners to create impactful solutions so that people can take charge of their futures and achieve their full potential. In the United States, we aim to ensure that everyone—especially those with the fewest resources—has access to the opportunities needed to succeed in school and life. Based in Seattle, Washington, the foundation is led by CEO Mark Suzman, under the direction of Bill Gates and our governing board.